tiprankstipranks
Trending News
More News >
Coherus Biosciences (CHRS)
NASDAQ:CHRS
US Market

Coherus Biosciences (CHRS) Cash flow

Compare
1,571 Followers

Coherus Biosciences Cash Flow

CHRS's free cash flow for Q4 2024 was $28.61M. For the 2024 fiscal year, CHRS's free cash flow was decreased by $154.73M and operating cash flow was $28.61M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -20.44M$ -174.88M$ -241.12M$ -37.43M$ 154.15M
Investing Cash Flow
$ 230.32M$ 144.64M$ -166.85M$ -138.41M$ -14.40M
Financing Cash Flow
$ -186.97M$ 69.60M$ 54.33M$ 51.88M$ 223.95M
End Cash Position
$ 126.25M$ 103.34M$ 63.99M$ 417.63M$ 541.60M
Free Cash Flow
$ -20.44M$ -175.17M$ -243.16M$ -38.72M$ 147.09M
Currency in USD

Coherus Biosciences Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis